Antisense oligonucleotides: an evolving technology for the modulation of gene expression in human disease.
Green
D W
DW
Department of Surgery, Washington University School of Medicine, St Louis, MO 63110, USA.
Roh
H
H
Pippin
J
J
Drebin
J A
JA
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D003424:Crohn Disease / Q000188:drug therapy / Q000235:genetics; D015870:Gene Expression; D006801:Humans; D008967:Molecular Biology; D009369:Neoplasms / Q000235:genetics*; D020319:Oligodeoxyribonucleotides, Antisense / Q000627:therapeutic use; D016376:Oligonucleotides, Antisense / Q000235:genetics / Q000627:therapeutic use; D014176:Protein Biosynthesis; D019908:Proto-Oncogene Proteins c-raf / Q000235:genetics; D012333:RNA, Messenger; D013873:Thionucleotides / Q000627:therapeutic use; D014170:Transformation, Genetic; D014652:Vascular Diseases / Q000188:drug therapy / Q000235:genetics
D000970:Antineoplastic Agents; D020319:Oligodeoxyribonucleotides, Antisense; D016376:Oligonucleotides, Antisense; D012333:RNA, Messenger; D013873:Thionucleotides; C108494:ISIS 3521; D019908:Proto-Oncogene Proteins c-raf